270 related articles for article (PubMed ID: 25154499)
1. Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
Wu T; Harder BG; Wong PK; Lang JE; Zhang DD
Mol Carcinog; 2015 Nov; 54(11):1494-502. PubMed ID: 25154499
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel.
Woo Y; Oh J; Kim JS
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718813
[TBL] [Abstract][Full Text] [Related]
3. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
4. Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells.
Ryoo IG; Choi BH; Kwak MK
Oncotarget; 2015 Apr; 6(10):8167-84. PubMed ID: 25717032
[TBL] [Abstract][Full Text] [Related]
5. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
Ryoo IG; Choi BH; Ku SK; Kwak MK
Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
7. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
8. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
Kang HJ; Yi YW; Hong YB; Kim HJ; Jang YJ; Seong YS; Bae I
Sci Rep; 2014 Dec; 4():7201. PubMed ID: 25467193
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of KEAP1 and NRF2 in PPARĪ³ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
[TBL] [Abstract][Full Text] [Related]
10. The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance.
Kahroba H; Shirmohamadi M; Hejazi MS; Samadi N
Life Sci; 2019 Dec; 239():116986. PubMed ID: 31678283
[TBL] [Abstract][Full Text] [Related]
11. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
12. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
13. Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway.
Tsai KJ; Tsai HY; Tsai CC; Chen TY; Hsieh TH; Chen CL; Mbuyisa L; Huang YB; Lin MW
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770867
[TBL] [Abstract][Full Text] [Related]
14. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
15. Brusatol overcomes chemoresistance through inhibition of protein translation.
Harder B; Tian W; La Clair JJ; Tan AC; Ooi A; Chapman E; Zhang DD
Mol Carcinog; 2017 May; 56(5):1493-1500. PubMed ID: 28019675
[TBL] [Abstract][Full Text] [Related]
16. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
[TBL] [Abstract][Full Text] [Related]
17. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
[TBL] [Abstract][Full Text] [Related]
18. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2.
Luo M; Bao L; Xue Y; Zhu M; Kumar A; Xing C; Wang JE; Wang Y; Luo W
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488001
[TBL] [Abstract][Full Text] [Related]
19. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
Ryoo IG; Lee SH; Kwak MK
Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
[TBL] [Abstract][Full Text] [Related]
20. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
